Australia's largest stock trading and investment forum Australia's #1 stock forum

BEZ

1.11%

8.9¢ besra gold inc.

@Tran Its also an old video from last year as well !Just put...

First 8 Last

Share
Profile

Follow
Tymmsy

1,557 Posts.

459

27/03/24

12:03

Post #: 73080972
Share

Originally posted by Tran: ↑

In that video the 3 amateur guys talked about "how can they pay the $300mil over 30 months? How can they produce the gold before all the money is paid to build the mine?". I stop watching it and had a good laugh because it shows these guys have no idea what they are talking about whatsoever.

Why?

It is because the mine is not going to be built tomorrow, not this year, maybe not next year. The company, just like any other mining projects out there, need to go through a whole lot of other activities before they are ready to build the mine. The DFS is not started yet. No ming permit yet (has been lodged recently). So, why the hell any customer want to commit all $300mil at once, now, today. For what? Just to let that big sum of money sit in the bank? Clearly these guys have no minimum basic knowledge of how a deposit can be turned into a producing mine. They clearly think a mine can be built tomorrow or in a few months.

And from the investor's perspective that is the off-take customer QM in this case, they need to see the project de-risked along the way to pay further deposits. In fact you will see all of deals like this from major giant mining powerhouses like Glencore, BHP,...when they sign a funding deal with a prospective mining company they always set milestones upon which they would release staged parcels of fund to the project. No one company would be stupid to throw a big sum of money into a project without certain milestones set.

Keep relying on those clueless guys for your investment decisions. But not for me. Thanks.

Expand

@Tran Its also an old video from last year as well !

Just put this guy on ignor

BEZ Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 977 more messages in this thread...

First 8 Last

Add BEZ (ASX) to my watchlist

(20min delay)
Last 8.9¢		Change -0.001(1.11%)		Mkt cap ! $37.39M

Open	High	Low	Value	Volume
9.0¢	9.0¢	8.9¢	$6.364K	70.83K

Buyers (Bids)

No.	Vol.	Price($)
2	72580	8.7¢

Sellers (Offers)

Price($)	Vol.	No.
8.9¢	3300	1

View Market Depth

No.	Vol.	Price($)
2	72580	0.087
2	82000	0.086
1	5000	0.084
1	11000	0.083
1	8024	0.082

Price($)	Vol.	No.
0.089	3300	1
0.090	100000	1
0.091	10000	1
0.092	56864	1
0.093	50000	1

Last trade - 11.23am 07/10/2024 (20 minute delay)

BEZ (ASX) Chart

@Tran Its also an old video from last year as well !Just put...

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

@Tran Its also an old video from last year as well !Just put...

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News